FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Pregabalin | Pregabalin 225 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-445 |
| Pregabalin | Pregabalin 300 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | Aug 3, 2026 | 29300-446 |
| Nintedanib esylate | Nintedanib esylate 100 mg/1 | CapsuleOral | Macleods Pharmaceuticals Limited | Aug 3, 2026 | 33342-550 |
| Nintedanib esylate | Nintedanib esylate 150 mg/1 | CapsuleOral | Macleods Pharmaceuticals Limited | Aug 3, 2026 | 33342-551 |
| Doxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | Aug 3, 2026 | 59762-1391 |
| Haloperidol | Haloperidol 5 mg/1 | TabletOral | Coupler LLC | Aug 3, 2026 | 67046-0329 |
| Amoxicillin | Amoxicillin 875 mg/1 | Tablet, Film coatedOral | Coupler LLC | Aug 3, 2026 | 67046-0734 |
| Carvedilol | Carvedilol 3.125 mg/1 | Tablet, Film coatedOral | Coupler LLC | Aug 3, 2026 | 67046-0973 |
| Bupropion Hydrochloride | Bupropion hydrochloride 100 mg/1 | Tablet, Film coatedOral | Coupler LLC | Aug 3, 2026 | 67046-1143 |
| Methocarbamol | Methocarbamol 500 mg/1 | TabletOral | Coupler LLC | Aug 3, 2026 | 67046-1177 |
| lithium carbonate | Lithium carbonate 150 mg/1 | CapsuleOral | Coupler LLC | Aug 3, 2026 | 67046-1690 |
| topiramate | Topiramate 100 mg/1 | Tablet, Film coatedOral | Coupler LLC | Aug 3, 2026 | 67046-1691 |
| Meclizine Hydrochloridemeclizine | Meclizine hydrochloride 25 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | Aug 3, 2026 | 68788-4170 |
| Pregabalin | Pregabalin 75 mg/1 | CapsuleOral | REMEDYREPACK INC. | Aug 3, 2026 | 70518-4715 |
| Pregabalin | Pregabalin 300 mg/1 | CapsuleOral | REMEDYREPACK INC. | Aug 3, 2026 | 70518-4716 |
| Phenobarbital | Phenobarbital 64.8 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 3, 2026 | 70518-4717 |
| Phenobarbital | Phenobarbital 32.4 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 3, 2026 | 70518-4718 |
| Phenobarbital | Phenobarbital 16.2 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 3, 2026 | 70518-4719 |
| Phenobarbital | Phenobarbital 97.2 mg/1 | TabletOral | REMEDYREPACK INC. | Aug 3, 2026 | 70518-4720 |
| Anastrozole | Anastrozole 1 mg/1 | TabletOral | Direct_Rx | Aug 3, 2026 | 72189-682 |
| Tadalafil | Tadalafil 2.5 mg/1 | Tablet, Film coatedOral | NorthStar Rx, LLC | Aug 3, 2026 | 72603-781 |
| Tadalafil | Tadalafil 5 mg/1 | Tablet, Film coatedOral | NorthStar Rx, LLC | Aug 3, 2026 | 72603-782 |
| Tadalafil | Tadalafil 10 mg/1 | Tablet, Film coatedOral | NorthStar Rx, LLC | Aug 3, 2026 | 72603-783 |
| Tadalafil | Tadalafil 20 mg/1 | Tablet, Film coatedOral | NorthStar Rx, LLC | Aug 3, 2026 | 72603-784 |
| Yesafiliaflibercept-jbvf | Aflibercept 2 mg/.05mL | Injection, SolutionIntravitreal | Biocon Biologics Inc. | Aug 3, 2026 | 83257-035 |